Cole Douglas G. 4
4 · Foghorn Therapeutics Inc. · Filed Jun 22, 2022
Insider Transaction Report
Form 4
Cole Douglas G.
Director
Transactions
- Award
Stock Options (Right to buy)
2022-06-21+16,000→ 16,000 totalExercise: $13.81From: 2023-06-21Exp: 2032-06-20→ Common Stock (16,000 underlying)